Acadia Pharmaceuticals | ACAD - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Cara Therapeutics USD 8.08M 3.18M 2026-09
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Cytokinetics USD 353.42M 171.99M 2026-09
Eisai JPY 371.5B 22.14B 2026-09
Eli Lilly USD 47B 745M 2026-09
Incyte USD 1.44B 125.72M 2026-09
J&J USD 55.46B 562M 2026-09
Moderna USD 2.03B 506M 2026-09
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Pfizer USD 31.73B 920M 2026-09
Prothena USD 11.43M 224K 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Vertex Pharmaceuticals USD 5B 1.06B 2026-09